(Q43789464)

26 November 2017

title

Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience (English)

1 reference

26 November 2017

main subject

United States of America

0 references

author name string

Pui CH

series ordinal

1

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

published in

Seminars in Hematology

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

4 Suppl 10

1 reference

26 November 2017

page(s)

13-21

1 reference

Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Urinary Xanthine Stones-a Rare Complication of Allopurinol Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Prevention and management of acute hyperuricemia in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Tumor lysis syndrome: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Advances in the management of malignancy-associated hyperuricaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990039-3

7 January 2021

10.1016/S0037-1963(01)90039-3

Identifiers

DOI

1 reference

26 November 2017

1 reference